John G. Connolly

Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA

Poster(s):

• (067) Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium Glucose Cotransporter 2 Inhibitors in the FDA Sentinel System
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (228) Beta-blocker-associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (316) The IMEDS Distributed Database Network and Pregnancy Studies
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (334) Characterization of COVID-19 vaccine data in the Sentinel System
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST